J. Goldman & Co’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.5M Buy
65,628
+36,302
+124% +$1.94M 0.08% 177
2025
Q1
$1.19M Buy
+29,326
New +$1.19M 0.03% 228
2023
Q4
Hold
0
208
2023
Q3
Hold
0
232
2023
Q2
Hold
0
238
2023
Q1
Hold
0
239
2022
Q4
Hold
0
258